https://ojs.bbwpublisher.com/index.php/PAR/issue/feed Proceedings of Anticancer Research 2025-02-20T09:01:12+08:00 Seven Gao info@bbwpublisher.com Open Journal Systems <p style="text-align: justify;"><em>Proceedings of Anticancer Research (PAR)&nbsp;</em>is an international peer-reviewed and open access journal, which is devoted to the rapid publication of high-quality original articles, reviews, case reports, short communication and letters on all aspects of experimental and clinical oncology.</p> <p style="text-align: justify;">The covered topics include, but are not limited to:&nbsp;cellular research and bio-markers, identification of bio-targets and agents with novel mechanisms of action, preventative and integrated treatments for cancer patients, radiation and surgery, palliative care, patient adherence, quality of life, satisfaction, and anticancer medicine,&nbsp;anticancer agents,&nbsp;novel therapies in development,&nbsp;cancer management,&nbsp;biomarkers,&nbsp;diagnostics,&nbsp;clinical trials,&nbsp;treatment guidelines.</p> <p align="justify">&nbsp;</p> https://ojs.bbwpublisher.com/index.php/PAR/article/view/9386 Application Value of Artificial Intelligence-Assisted Diagnostic Systems in CT Diagnosis of Pulmonary Nodules 2025-01-16T15:13:35+08:00 Yang Xue 26917269@qq.com Mingqiang Diao 26917269@qq.com Bing Han 26917269@qq.com <p><strong><em>Objective</em></strong><em>:</em> To explore the application value of artificial intelligence-assisted diagnostic systems in the computed tomography (CT) diagnosis of pulmonary nodules. <strong><em>Methods</em></strong><em>:</em> A total of 80 patients with pulmonary nodules, treated from June 2023 to May 2024, were included. All patients underwent pathological examination and CT scans, with pathological results serving as the gold standard. The diagnostic performance of CT alone and CT combined with the artificial intelligence-assisted diagnostic system was analyzed, and differences in CT imaging features and evaluation results of benign and malignant pulmonary nodules were compared. <strong><em>Results</em></strong><em>:</em> The sensitivity, specificity, and accuracy of CT combined with the artificial intelligence-assisted diagnostic system were significantly higher than those of CT alone (<em>P</em> &lt; 0.05). Moreover, the false-positive and false-negative rates were significantly lower for the combined approach compared to CT alone (<em>P</em> &lt; 0.05). <strong><em>Conclusion</em></strong><em>:</em> The artificial intelligence-assisted diagnostic system effectively identifies malignant features in pulmonary nodules, providing valuable clinical reference data and enhancing diagnostic accuracy and efficiency.</p> 2025-01-16T15:00:45+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9453 Advantages and Application Prospects of Traditional Chinese Medicine Granules 2025-02-13T09:26:42+08:00 Xiaohua Sun 478512346@qq.com <p>With the advancement of the modernization of traditional Chinese medicine (TCM), TCM granules have emerged and garnered widespread attention. This study provides a comprehensive review of the development of TCM granules, analyzing their characteristics in terms of ease of use, quality stability, and pharmacodynamic advantages. It also explores their broad application prospects in clinical TCM treatment and preventive healthcare. Through an integrative analysis of relevant research literature, the study highlights the significant value and vast development potential of TCM granules in modern medicine. The article aims to offer valuable references for the modernization and internationalization of TCM while promoting the continuous development and innovative application of TCM granules in the field of traditional Chinese medicine.</p> 2025-02-13T09:19:06+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9454 Effectiveness of High-Frequency Electrosurgical Knife Surgery Under Painless Digestive Endoscopy in Elderly Patients with Gastrointestinal Polyps 2025-02-13T16:05:18+08:00 Yumin Lu benben812@163.com <p><em>Objective:</em> To analyze the therapeutic effect of high-frequency electrosurgical knife surgery guided by painless digestive endoscopy (PDE) in elderly patients with gastrointestinal polyps (GP). <em>Methods:</em> A total of 100 elderly GP patients admitted between June 2021 and December 2022 were selected. Patients were randomly divided into two groups: the painless group (50 cases) underwent high-frequency electrosurgical knife surgery guided by PDE, while the conventional group (50 cases) underwent the same surgery guided by traditional digestive endoscopy (DE). The total treatment efficacy, perioperative indicators, gastrointestinal hormone levels, oxidative stress (OS) markers, and complication rates were compared between the two groups. <em>Results:</em> The total treatment efficacy in the painless group was higher than that in the conventional group, and perioperative indicators were superior in the painless group (<em>P</em> &lt; 0.05). One week after treatment, the gastrointestinal hormone levels and OS-related markers in the painless group were better than those in the conventional group (<em>P</em> &lt; 0.05). The complication rate in the painless group was lower than in the conventional group (<em>P</em> &lt; 0.05). <em>Conclusion:</em> High-frequency electrosurgical knife surgery guided by PDE improves the effectiveness of polyp removal in elderly GP patients and accelerates postoperative recovery. It also protects gastrointestinal function, reduces postoperative OS, and ensures higher surgical safety.</p> 2025-02-13T16:03:57+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9455 Effectiveness of Multi-Modal Teaching Based on Online Case Libraries in the Education of Gene Methylation Combined with Spiral CT Screening for Pulmonary Ground-Glass Opacity Nodules 2025-02-13T16:05:21+08:00 Yong Zhou youshupin@163.com Xi Zhang youshupin@163.com Shuyi Liu youshupin@163.com Zhouyi He youshupin@163.com Weili Tian youshupin@163.com Shuping You youshupin@163.com <p><em>Objective:</em> To explore the effectiveness of multi-modal teaching based on an online case library in the education of gene methylation combined with spiral computed tomography (CT) screening for pulmonary ground-glass opacity (GGO) nodules. <em>Methods:</em> From October 2023 to April 2024, 66 medical imaging students were selected and randomly divided into a control group and an observation group, each with 33 students. The control group received traditional lecture-based teaching, while the observation group was taught using a multi-modal teaching approach based on an online case library. Performance on assessments and teaching quality were analyzed between the two groups. <em>Results:</em> The observation group achieved higher scores in theoretical and practical knowledge compared to the control group (<em>P</em> &lt; 0.05). Additionally, the teaching quality scores were significantly higher in the observation group (<em>P</em> &lt; 0.05). <em>Conclusion:</em> Implementing multi-modal teaching based on an online case library for pulmonary GGO nodule screening with gene methylation combined with spiral CT can enhance students’ knowledge acquisition, improve teaching quality, and have significant clinical application value.</p> 2025-02-13T15:35:59+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9456 Infrared Thermography-Based Predictive Model for Syndrome Differentiation of Chaihu Guizhi Ganjiang Decoction 2025-02-14T10:56:44+08:00 Huisi Hong honghuisi@zsszyy.net Yiming Yuan honghuisi@zsszyy.net Na Li honghuisi@zsszyy.net Xiaoxing Huang honghuisi@zsszyy.net Leyu Li honghuisi@zsszyy.net Tingting Zeng 624219125@qq.com <p><em>Objective:</em> To evaluate the use of infrared thermography technology for objective and quantitative syndrome differentiation and treatment in traditional Chinese medicine (TCM), specifically in patients with Chaihu Guizhi Ganjiang Decoction syndrome. <em>Methods:</em> Data were collected from over 100 patients diagnosed with Chaihu Guizhi Ganjiang Decoction syndrome at Professor Li Leyu’s endocrinology clinic, Zhongshan Hospital of Traditional Chinese Medicine, Guangdong Province, between April 2021 and April 2022. Body surface temperature data were obtained using the MTI-EXPRO-2013-B infrared thermography system. Principal component analysis (PCA) was applied to differentiate temperature distribution characteristics between genders, and a neural network prediction model was constructed for syndrome diagnosis. <em>Results:</em> Infrared thermography effectively captured surface temperature characteristics of patients with Chaihu Guizhi Ganjiang Decoction syndrome. PCA identified one principal component with a variance explanation rate of 73.953% for females and two principal components with a cumulative variance explanation rate of 77.627% for males. The neural network model demonstrated high predictive performance, with an area under the ROC curve of 0.9743 for the training set and 0.9889 for the validation set. Sensitivity was 1, specificity 0.8636, precision 0.8846, accuracy 0.9333, and the F1 score 0.9388. <em>Conclusion:</em> Infrared thermography provides an innovative, objective, and quantitative method for syndrome differentiation and treatment in TCM. It represents a significant advancement in transitioning from traditional empirical approaches to modern, visualized, and precise diagnosis and treatment. This study underscores the potential of integrating advanced technologies in TCM for enhanced clinical application and modernization.</p> 2025-02-14T08:57:49+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9458 Advances in Artificial Intelligence for Predicting Breast Cancer Using Chest CT Scans 2025-02-13T11:04:59+08:00 Jingxiang Sun suenjx611@163.com Guang Zhang suenjx611@163.com <p>Breast cancer is the most common malignant tumor among women worldwide, with its incidence and mortality ranking first among all cancers. Early diagnosis and treatment significantly improve prognosis and reduce disease-related mortality. Chest computed tomography (CT), a routine examination for physical assessments and hospitalized patients, can screen for the presence of breast nodules and provide an initial assessment of malignancy risk. In recent years, artificial intelligence (AI) has advanced rapidly in the medical field. Studies have demonstrated that the sensitivity and accuracy of chest CT in diagnosing breast cancer are enhanced through the application of AI methods. This article explores the research progress in breast cancer diagnosis utilizing artificial intelligence based on chest CT examinations.</p> 2025-02-13T10:57:33+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9136 Advances in Radiomics for Individualized and Precision-Based Diagnosis and Treatment of Lung Cancer 2025-02-13T09:26:39+08:00 Tongtong Liu hyshi2015@163.com Fang Wang hyshi2015@163.com Shuai Qie hyshi2015@163.com Xuefeng Wang hyshi2015@163.com Kuan Liu hyshi2015@163.com Yang Li hyshi2015@163.com Hongyun Shi hyshi2015@163.com <p>Lung cancer is among the most prevalent cancers and has the highest mortality rate globally. The diagnosis, pathohistological classification, and molecular testing of lung cancer primarily rely on tissue biopsy or surgical resection. These methods are invasive and associated with limitations, including sample quantity and quality, as well as patient tolerance. Radiomics, an emerging technology, enables the extraction of high-throughput quantitative information from medical images, providing radiomic features applicable to clinical diagnosis and treatment. Significant advancements have been made in the application of radiomics to the diagnosis, molecular detection, efficacy prediction, and prognosis of lung cancer. This review examines the progress in radiomics for individualized and precise diagnosis and treatment of lung cancer in recent years.</p> 2025-02-13T09:23:12+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9264 The High Expression of EXOSC3 in OSCC is Associated with Poor Prognosis and Immune Infiltration 2025-02-13T11:07:49+08:00 Yucunxi Liu yangdunhui1993@163.com Jianguo Liu 852235104@qq.com <p>Oral squamous cell carcinoma (OSCC) is the most common malignant tumor in the oral and maxillofacial region, primarily affecting the tongue, gingiva, oral cavity, buccal mucosa, and floor of the mouth. It exhibits high rates of recurrence and metastasis, contributing to a poor prognosis for patients. Identifying molecular markers associated with OSCC holds significant value for advancing its diagnosis, treatment, and prognosis. <em>Exosome Component 3</em> (<em>EXOSC3</em>) is a protein-coding gene involved in the auto-degradation of E3 ubiquitin ligase COP 1 and rRNA processing in the nucleus and cytoplasmic sol. This gene plays a crucial role in diseases such as colon cancer and non-small cell lung cancer. Bioinformatics analysis revealed that <em>EXOSC3</em> expression is significantly elevated in OSCC and is associated with poor patient prognosis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses indicate that <em>EXOSC3</em> is strongly linked to the cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, and JAK-STAT signaling pathway. Moreover, immune infiltration analysis demonstrated a significant association between <em>EXOSC3</em> expression and immune cell subset infiltration, as well as immune checkpoint expression, underscoring its importance in OSCC. However, further research is required to elucidate the specific role of <em>EXOSC3</em> in OSCC diagnosis and treatment. A comprehensive investigation into the mechanisms of <em>EXOSC3</em> in OSCC may reveal new potential targets for improving the diagnosis and treatment of this malignancy.<br><br style="display: none !important;"><span class="transmart-tgt-container" style="display: none !important;"><span class="transmart-tgt-wrapper">口腔鳞状细胞癌(Oral squamous cell carcinoma,OSCC)是口腔颌面部最常见的恶性肿瘤,主要发生在舌、牙龈、口腔、颊粘膜和口底等部位。它具有高度复发性和转移性,导致患者预后不良。因此,寻找与口腔鳞状细胞癌相关的分子标志物对口腔鳞状细胞癌的诊断、治疗和预后具有重要意义。Exosome Component 3是一种蛋白质编码基因,与E3泛素连接酶COP 1的自身降解以及rRNA在细胞核和细胞质溶胶中的加工有关,在结肠癌和非小细胞肺癌中发挥重要作用。通过生物信息学,我们发现EXOSC 3在OSCC中的表达显著增加,并且与患者预后不良相关。GO和KEGG富集分析显示EXOSC 3与细胞因子-细胞因子受体相互作用、Toll样受体信号通路和JAK-STAT信号通路显著相关。此外,免疫浸润分析显示,EXOSC 3与免疫细胞亚群的浸润和免疫检查点的表达显著相关,突出了EXOSC 3在OSCC中的重要性。然而,需要进一步的研究来确定EXOSC 3对口腔鳞癌诊断和治疗的具体影响。这将有助于我们全面了解EXOSC 3在OSCC中的作用机制,为OSCC的诊断和治疗提供新的潜在靶点。</span></span></p> 2025-02-13T09:23:50+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9459 Comparative Effectiveness of Medical Radiation Protection Spray and Triethanolamine Cream in Preventing and Treating Radiodermatitis in Breast Cancer Patients 2025-02-13T11:04:55+08:00 Yuge Ran hyshi2015@163.com Chan Liu hyshi2015@163.com Lanhui Yuan hyshi2015@163.com Huibin Yang hyshi2015@163.com Lei Su hyshi2015@163.com Kunjie Wang hyshi2015@163.com Qianqian Han hyshi2015@163.com Xiaoxi Wu hyshi2015@163.com Hongyun Shi hyshi2015@163.com <p><em>Objective:</em> This study investigates the preventive and therapeutic effects of medical radiation protection spray (Bergmann) compared to triethanolamine cream in patients undergoing radiotherapy following breast cancer surgery. <em>Methods:</em> Ninety patients with breast cancer who received postoperative radiotherapy between July 2018 and July 2021 were randomly divided into the Bergmann treatment (experimental) group and the triethanolamine cream treatment (control) group, with 45 patients in each group. Radiodermatitis severity was assessed using the RTOG radiodermatitis grading standards. <em>Results:</em> The radiation dose required to develop grade I radiodermatitis was significantly higher in the experimental group compared to the control group, at (36.13 ± 1.17 Gy) and (25.38 ± 0.63 Gy), respectively. At a radiation dose of 30 Gy, the proportion of grade I radiodermatitis cases in the experimental group was significantly lower than in the control group (<em>P</em> = 0.002). At radiation doses of 40 Gy and 50 Gy, the proportion of grade II radiodermatitis cases in the experimental group was also significantly lower than in the control group (<em>P</em> &lt; 0.001). No cases of grade III or higher radiodermatitis were observed in the experimental group, while three cases of grade III radiodermatitis occurred in the control group, although the difference was not statistically significant. No patients in the experimental group discontinued treatment due to radiodermatitis or mucosal reactions, whereas two patients in the control group interrupted treatment due to these reactions but eventually completed therapy. <em>Conclusion:</em> Bergmann spray effectively prevents radiodermatitis in patients undergoing radiotherapy after breast cancer surgery and is more effective than triethanolamine cream in treating skin lesions. Its ease of use improves the quality of life for patients undergoing radiotherapy and ensures successful treatment completion. Bergmann is suitable for clinical promotion and application.</p> 2025-02-13T10:58:36+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9142 Research Progress on the Mechanism of Action of Traditional Chinese Medicine Extracts in the Prevention and Treatment of Periodontitis 2025-02-13T11:08:49+08:00 Ke Tian tianke930129@163.com Rao Lu 494591918@qq.com Tang Jing htkw890104@163.com <p>Periodontitis is an inflammatory infectious disease affecting the periodontal supporting tissues and is the primary cause of tooth loosening and tooth loss in adults. Clinically, supragingival scaling, subgingival scaling, root planing, and other basic periodontal treatments, often combined with antibiotic therapy, are commonly employed with moderate efficacy. However, the increasing prevalence of antibiotic resistance and associated adverse reactions has become a growing concern. Recent studies have demonstrated the significant impact of traditional Chinese medicine (TCM) extracts in both the prevention and treatment of periodontitis, exhibiting remarkable effectiveness. This review explores the role and mechanisms of TCM extracts in the prevention and treatment of periodontitis, providing a reference for further elucidation of their mechanisms and a theoretical basis for the development of Chinese herbal medicine-based care products.<br><br style="display: none !important;"><span class="transmart-tgt-container" style="display: none !important;"><span class="transmart-tgt-wrapper">牙周炎是一种发生于牙周支持组织的炎症性感染性疾病,是成年人牙齿松动和脱落的主要原因。在临床上,龈上洁治、龈下洁治、根面平整等牙周基础治疗,结合抗生素治疗,通常都有较好的疗效。然而,抗生素耐药性和不良反应越来越普遍。近年来,大量的研究表明,中药提取物在预防和治疗牙周炎方面具有显著的影响,具有特殊的效果。因此,本文就中药提取物在牙周炎防治中的作用及机制进行综述,为深入阐明中药提取物防治牙周炎的作用机制提供参考,并为中草药护理产品的开发提供理论依据。</span></span></p> 2025-02-13T09:24:41+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9461 Symptom Experiences and Coping Patterns in Pancreatic Cancer Patients During Chemotherapy: A Qualitative Study 2025-02-20T09:01:12+08:00 Xin Tian qshi@cqmu.edu.cn Ping Chen qshi@cqmu.edu.cn Wen Zhou qshi@cqmu.edu.cn Peiyang Mao qshi@cqmu.edu.cn Jian Li qshi@cqmu.edu.cn Cheng Lei qshi@cqmu.edu.cn Xiaojing Xue qshi@cqmu.edu.cn Changlin Li qshi@cqmu.edu.cn Yuxuan Nie qshi@cqmu.edu.cn Feng Gao qshi@cqmu.edu.cn Jie Li qshi@cqmu.edu.cn Gang Feng qshi@cqmu.edu.cn Xiaobo Du qshi@cqmu.edu.cn Qiuling Shi qshi@cqmu.edu.cn Jingyu Zhang zhangjingyu0304@cqmu.edu.cn <p><em>Objective:</em> To explore symptom experiences and self-coping patterns during the early and late stages of chemotherapy in these patients to provide a basis for developing targeted symptom management strategies. <em>Methods:</em> A total of 27 patients with pancreatic cancer undergoing chemotherapy at two medical institutions were recruited between November 2023 and August 2024. Semi-structured interviews were conducted in person or over the phone. Data were analyzed using traditional content and thematic analyses. <em>Results:</em> Three themes were identified: symptom experience, self-coping patterns, and existing obstacles. During the early stages of chemotherapy, patients reported a higher frequency of unpleasant symptoms and recognized these symptoms earlier in the treatment course. Patients in the early stages primarily relied on external support to cope with symptoms, while those in the later stages adopted self-care strategies. Several challenges related to unpleasant symptoms were observed, which appeared to correlate with the self-coping patterns employed. <em>Conclusion:</em> Patients with pancreatic cancer undergoing chemotherapy experience a complex and diverse range of symptoms, with varying coping patterns at different stages of treatment. Symptom management during chemotherapy presents significant challenges. Healthcare providers should improve the ongoing monitoring of symptoms post-chemotherapy. By linking patients’ symptom experiences and self-coping patterns at different stages of chemotherapy to their specific challenges, personalized symptom management strategies can be developed to enhance care quality.</p> 2025-02-13T10:59:43+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9360 The Predictive Value of SPP1 Gene Expression for the Survival of Advanced Liver Cancer Treated with Transarterial Chemoembolization 2025-02-13T11:05:03+08:00 Yu Cai jxzlkzk@126.com Pu Yan sxyanpu@163.com Chang Tian sxyanpu@163.com Yuqing Li sxyanpu@163.com Yuanyuan Jia sxyanpu@163.com Siqi Wang sxyanpu@163.com <p><em>Objective:</em> To evaluate the predictive value of <em>secreted phosphoprotein 1</em> (<em>SPP1</em>) gene expression for postoperative survival in patients with advanced liver cancer undergoing hepatic artery interventional chemoembolization treatment. <em>Method:</em> Bioinformatics methods, including gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, were used to identify genes related to survival prognosis in hepatocellular carcinoma (HCC) patients. A retrospective analysis of 115 advanced liver cancer patients treated between January 2016 and October 2017 was conducted. Patients were categorized into <em>SPP1</em> high-expression (<em>n</em> = 89) and low-expression groups (<em>n</em> = 26). Additionally, 115 healthy individuals served as the control group. The relationship between <em>SPP1</em> expression and clinical pathological features was analyzed. A 60-month follow-up and logistic regression analysis identified risk factors affecting survival. <em>Results:</em> SPP1 mRNA expression was significantly higher in liver cancer patients compared to healthy controls (<em>P</em> &lt; 0.05). <em>SPP1</em> expression levels were significantly associated with tumor size, Child-Pugh grading, lymph node metastasis, and BCLC staging (<em>P</em> &lt; 0.05). High <em>SPP1</em> expression, along with tumor size, Child-Pugh grading, lymph node metastasis, and BCLC staging, were independent risk factors for survival (<em>P</em> &lt; 0.05). The 60-month survival rate was 17.39%, with a median survival of 40 months in the low-expression group versus 18 months in the high-expression group (<em>P</em> &lt; 0.05). <em>Conclusion:</em> SPP1 expression is significantly upregulated in advanced liver cancer patients and has predictive value for postoperative survival following hepatic artery chemoembolization treatment. SPP1, combined with clinical indicators such as tumor size, Child-Pugh grading, lymph node metastasis, and BCLC staging, may serve as a prognostic biomarker for interventional treatment outcomes.</p> 2025-02-13T00:00:00+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9623 Clinical Efficacy and Safety Analysis of Toripalimab Combined with GC Chemotherapy for Advanced Urothelial Carcinoma 2025-02-13T11:04:47+08:00 Song Xue 745501416@qq.com Dongli Ruan 745501416@qq.com <p><em>Objective:</em> To analyze the clinical efficacy and safety of toripalimab combined with the GC chemotherapy regimen in the treatment of advanced urothelial carcinoma. <em>Methods:</em> A retrospective study was conducted on 102 patients with advanced urothelial carcinoma treated at our hospital between March 2021 and August 2024. Based on treatment regimens, patients were divided into a chemotherapy group (<em>n</em> = 52) and a combination group (<em>n</em> = 50). The chemotherapy group received the GC chemotherapy regimen, while the combination group received GC chemotherapy combined with toripalimab. Both groups underwent 4–6 cycles of treatment based on patient tolerance. Clinical efficacy, immune-related factor levels, survival outcomes, and safety were observed and compared. <em>Results:</em> The disease control rate (DCR) and overall response rate (ORR) in the combination group were slightly higher than those in the chemotherapy group, but the differences were not statistically significant (<em>P</em> &gt; 0.05). After treatment, levels of IFN-γ and IL-2 increased significantly, while VEGF levels decreased significantly in both groups (<em>P</em> &lt; 0.05), with superior outcomes observed in the combination group (<em>P</em> &lt; 0.05). Follow-up analysis showed progression-free survival (PFS) and median overall survival (OS) in the chemotherapy group were 5.19 and 10.15 months, respectively, compared to 8.24 and 18.23 months in the combination group, with statistically significant differences (<em>P</em> &lt; 0.05). During treatment, the incidence of adverse reactions such as rash, immune-related pneumonia, and immune-related diarrhea was higher in the combination group than in the chemotherapy group (<em>P</em> &lt; 0.05). However, the incidence of gastrointestinal reactions, fever, and leukopenia did not differ significantly between the two groups (<em>P</em> &gt; 0.05). <em>Conclusion:</em> The use of toripalimab combined with the GC chemotherapy regimen for advanced urothelial carcinoma can effectively improve clinical outcomes and extend patient survival, with good overall safety. However, attention should be given to preventing adverse reactions such as rash and pneumonia during treatment.</p> 2025-02-13T11:01:43+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9462 Application of Artificial Neural Networks in Predicting Malignant Lung Nodules on Chest CT Scans 2025-02-13T16:05:25+08:00 Wenhui Li 1501120187@qq.com Yuping Yang 1501120187@qq.com Yixian Liang 1501120187@qq.com Pengliang Xu 1501120187@qq.com Qiuqiang Chen 1501120187@qq.com <p><em>Objective:</em> To explore a simple method for improving the diagnostic accuracy of malignant lung nodules based on imaging features of lung nodules. <em>Methods:</em> A retrospective analysis was conducted on the imaging data of 114 patients who underwent lung nodule surgery in the Thoracic Surgery Department of the First People’s Hospital of Huzhou from June to September 2024. Imaging features of lung nodules were summarized and trained using a BP neural network. <em>Results:</em> Training with the BP neural network increased the diagnostic accuracy for distinguishing between benign and malignant lung nodules based on imaging features from 84.2% (manual assessment) to 94.1%. <em>Conclusion:</em> Training with the BP neural network significantly improves the diagnostic accuracy of lung nodule malignancy based solely on imaging features.</p> 2025-02-13T14:39:50+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9624 Study on the Clinical Efficacy of Levofloxacin Combined with Ambroxol in the Treatment of Elderly Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Infection 2025-02-14T10:56:41+08:00 Yuanyuan Chen 15665733858@163.com <p><em>Objective:</em> To investigate the clinical efficacy of levofloxacin combined with ambroxol in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD) and pulmonary infection. <em>Methods:</em> A total of 80 elderly COPD patients with pulmonary infection, treated between December 2022 and November 2023, were randomly divided into a control group and an observation group, with 40 cases in each group. The control group was treated with levofloxacin hydrochloride, while the observation group received ambroxol hydrochloride injection in addition to the treatment in the control group. Laboratory indices (white blood cell count, procalcitonin, C-reactive protein, and apolipoprotein E levels), imaging-based pulmonary lesion absorption time, hospital stay, and incidence of adverse reactions were compared between the two groups. <em>Results:</em> After treatment, the biochemical indices of the observation group were significantly lower than those of the control group, with highly significant differences (<em>P</em> &lt; 0.001). Compared to the control group, the imaging-based pulmonary lesion absorption time and hospital stay of the observation group were significantly shorter (<em>P</em> &lt; 0.001). Additionally, the incidence of adverse reactions in the observation group was significantly lower than in the control group (<em>P</em> &lt; 0.05). <em>Conclusion:</em> Levofloxacin combined with ambroxol demonstrates advantages in improving biochemical indices, shortening imaging-based pulmonary lesion absorption time and hospital stay, and reducing adverse reaction rates in elderly COPD patients with pulmonary infection. It holds significant clinical application value.</p> 2025-02-14T10:29:07+08:00 Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/PAR/article/view/9463 Plasma Technology: Unlocking a New Path for Precise Elimination of Cancer Cells 2025-02-13T09:26:31+08:00 Jie Bai 13366667724@qq.com <p>This paper systematically elucidates the application of plasma technology in cancer treatment, including its principles, case studies, comparative advantages over traditional methods, challenges, and countermeasures. Plasma technology targets and eliminates cancer cells with precision through physical, chemical, and immune-regulatory mechanisms, offering high accuracy and low side effects. International applications include plasma scalpels in the United States, combined chemotherapy and low-temperature plasma therapy in Russia, and plasma-targeted capture technology in China. However, plasma technology faces technical hurdles and clinical application barriers, requiring interdisciplinary collaboration and industry-academia-research cooperation to advance its development.</p> 2025-02-13T09:25:41+08:00 Copyright (c) 2025 Author(s)